Brief: Dermapharm Q1 Adjusted EBITDA EUR 87.4 Million

Dermapharm Holding SE

13/05/2026 06:44

May 13 (Reuters) - Dermapharm Q1 revenue EUR 305.8 million.

Q1 EBITDA margin 29.8%

Q1 adjusted EBITDA margin 28.6%

Q1 EBITDA EUR 91.2 million